KINEX LABS products are sold exclusively for in-vitro research and laboratory use. By entering, you confirm you are 18 or older and a qualified researcher, and you will not use these compounds for human consumption.
CJC-1295 (without DAC) 10 mg is a modified GHRH analogue under investigation in growth-hormone pulse research. Without the DAC modification, it produces a shorter-acting pulse profile compared to the DAC version.
Research Profile
Modified GHRH analogue (no DAC)
Studied in pulsatile GH release and IGF-1 research
Often researched in combination with Ipamorelin
QC verified by HPLC and mass spectrometry
Specifications
Compound: CJC-1295 (without DAC)
Dosage: 10 mg per vial
Purity: ≥ 98% (HPLC)
Form: Lyophilized powder
Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Specifications
Compound
CJC-1295 (without DAC)
Class
GHRH analogue (modified, no Drug Affinity Complex)
Dosage
10 mg per vial
Purity
≥ 98% (HPLC)
Form
Lyophilized powder
Appearance
White to off-white cake
Storage
Store lyophilized at 2–8 °C. Reconstituted: –20 °C, use within 30 days.
Reconstitution
Bacteriostatic water (sold separately)
Research Use
Investigational compound for laboratory research only.
